Key Metrics
CiteScore 

8.3
SJR 

Q2Virology

SNIP 

1.44
Recommended pre-submission checks
Powered by 

Topics Covered on Tumour Virus Research
Tumour Virus Research Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 900 |
| Publication Time | 14 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Tumour Virus Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Tumour Virus Research
30-hydroxygambogic acid activates overlapping and independent apoptotic pathways in HPV positive and HPV negative oral cancer cells.
- 1 Jun 2026
- Tumour virus research
HPV18E6 and CDK5 virus-host interaction is a prospective therapeutic target for HPV-positive cervical cancer.
- 1 Jun 2026
- Tumour virus research
Oncolytic virus hijacks GOT1 and pyrimidinosomes to fuel pyrimidine synthesis for replication in tumor cells.
- 1 Jun 2026
- Tumour virus research
Susceptibility of naturally human papillomavirus type 16 major capsid protein L1 variants to vaccines and predictions of future evolutionary trends.
- 1 Jun 2026
- Tumour virus research
PRMT5–mediated symmetric dimethylation of SHBs at Arg169 stabilizes SHBs and promotes angiogenesis and tumor growth
- 26 Mar 2026
- Tumour Virus Research
Ad-VT oncolytic adenovirus suppresses bladder cancer via cAMP-dependent AMPK-Raptor activation and G2/M arrest
- 29 Jan 2026
- Tumour Virus Research
30-hydroxygambogic acid activates overlapping and independent apoptotic pathways in HPV positive and HPV negative oral cancer cells.
- 1 Jun 2026
- Tumour virus research
HPV18E6 and CDK5 virus-host interaction is a prospective therapeutic target for HPV-positive cervical cancer.
- 1 Jun 2026
- Tumour virus research
Oncolytic virus hijacks GOT1 and pyrimidinosomes to fuel pyrimidine synthesis for replication in tumor cells.
- 1 Jun 2026
- Tumour virus research
Susceptibility of naturally human papillomavirus type 16 major capsid protein L1 variants to vaccines and predictions of future evolutionary trends.
- 1 Jun 2026
- Tumour virus research
PRMT5–mediated symmetric dimethylation of SHBs at Arg169 stabilizes SHBs and promotes angiogenesis and tumor growth
- 26 Mar 2026
- Tumour Virus Research
Ad-VT oncolytic adenovirus suppresses bladder cancer via cAMP-dependent AMPK-Raptor activation and G2/M arrest
- 29 Jan 2026
- Tumour Virus Research
FAQs on Tumour Virus Research
What is the publishing frequency of Tumour Virus Research? 
How many articles did Tumour Virus Research publish last year? 
What is the eISSN & pISSN for Tumour Virus Research? 
What is Citescore for Tumour Virus Research? 
What is SNIP score for Tumour Virus Research? 
What is the SJR for Tumour Virus Research? 
Who is the publisher of Tumour Virus Research? 
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary